Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Alcon Research |
---|---|
Information provided by: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00047541 |
To compare intraocular pressure lowering effectiveness of a combination drug vs. two individual drugs dosed alone.
Condition | Intervention | Phase |
---|---|---|
Open-Angle Glaucoma Ocular Hypertension |
Drug: Alcon Investigational Agent |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Phase III Safety and Efficacy Study to Evaluate Combination IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertensive Patients C-01-70. |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension; visual acuity of 20/80 to 20/400 or better (Snellen equivalent) or logMAR visual acuity not worse than 0.6. Clinically relevant ophthalmic or systemic conditions may be excluded.
Study ID Numbers: | C-01-70, C-01-70 |
Study First Received: | October 8, 2002 |
Last Updated: | August 4, 2008 |
ClinicalTrials.gov Identifier: | NCT00047541 |
Health Authority: | United States: Food and Drug Administration |
open-angle glaucoma ocular hypertension POAG |
Glaucoma Eye Diseases Glaucoma, Open-Angle |
Vascular Diseases Hypertension Ocular Hypertension |
Cardiovascular Diseases |